Micro Labs Limited — Ciprofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #15 for Ciprofloxacin · $4.2M export value · DGFT Verified
Micro Labs Limited is the #15 Indian exporter of Ciprofloxacin with $4.2M in export value and 101 verified shipments. Micro Labs Limited holds a 1.4% market share in Ciprofloxacin exports across 11 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Ciprofloxacin Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Ciprofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| VIETNAM | $594.1K | 13 | 24.4% |
| VIETNAM, DEMOCRATIC REP. OF | $461.1K | 10 | 19.0% |
| JORDAN | $434.8K | 22 | 17.9% |
| VIETNAM DEMOCRATIC REP. OF | $342.1K | 12 | 14.1% |
| IRAQ | $215.9K | 8 | 8.9% |
| THAILAND | $157.8K | 4 | 6.5% |
| CAMBODIA | $138.9K | 10 | 5.7% |
| NETHERLANDS | $54.5K | 6 | 2.2% |
| PAKISTAN | $17.3K | 3 | 0.7% |
| PAPUA NEW GUINEA | $7.9K | 1 | 0.3% |
Micro Labs Limited exports Ciprofloxacin to 13 countries. The largest destination is VIETNAM accounting for 24.4% of Micro Labs Limited's Ciprofloxacin shipments, followed by VIETNAM, DEMOCRATIC REP. OF (19.0%) and JORDAN (17.9%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ciprofloxacin from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DANANG PHARMACEUTICAL- | VIETNAM, DEMOCRATIC REP. OF | $736.2K | 21 |
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $595.6K | 28 |
| DA NANG PHARMACEUTICAL MEDICAL | VIETNAM | $400.0K | 8 |
| ATLANTA MEDICARE CO. LTD | THAILAND | $150.0K | 3 |
| DANANG PHARMACEUTICAL-MEDICAL | VIETNAM | $150.0K | 3 |
| PPS INTERNATIONAL CO. LTD | CAMBODIA | $108.0K | 8 |
| DANANG PHARMACEUTICAL | VIETNAM | $100.0K | 2 |
| AL KAWKAB SCIENTIFIC BUREAU | JORDAN | $55.1K | 2 |
| BERZAN INTERPHARM | NETHERLANDS | $48.0K | 5 |
| PPS INTERNATIONAL CO LTD | CAMBODIA | $21.7K | 1 |
Micro Labs Limited supplies Ciprofloxacin to 25 buyers globally. The largest buyer is DANANG PHARMACEUTICAL- (VIETNAM, DEMOCRATIC REP. OF), followed by AL-KAWKAB SCIENTIFIC BUREAU (JORDAN) and DA NANG PHARMACEUTICAL MEDICAL (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ciprofloxacin Export Value and How Much Does Micro Labs Limited Contribute?
India exported $74.6M worth of Ciprofloxacin through 14,146 shipments from 1001 suppliers to 180 countries, serving 3,081 buyers globally. Micro Labs Limited contributes $4.2M to this total, accounting for 1.4% of India's Ciprofloxacin exports. Micro Labs Limited ships Ciprofloxacin to 13 countries through 25 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Ciprofloxacin Exports?
Micro Labs Limited's average Ciprofloxacin shipment value is $41.8K per consignment, based on 101 shipments totaling $4.2M. The largest destination is VIETNAM (24.4% of Micro Labs Limited's Ciprofloxacin exports).
How Does Micro Labs Limited Compare to Other Indian Ciprofloxacin Exporters?
Micro Labs Limited ranks #15 among 1001 Indian Ciprofloxacin exporters with a 1.4% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($20.4M), AUROBINDO PHARMA LTD ($11.4M), SENTISS PHARMA PRIVATE LIMITED ($8.8M). Micro Labs Limited processed 101 shipments to 11 destination countries.
What Ciprofloxacin Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MICROLUSS (CIPROFLOXACIN TABLETS USP 500 | $250.0K | 5 |
| MICROLUSS (CIPROFLOXACIN TABLETS USP 500MG) (10X10SX51896) - TAX INVOICE NO: 701208452 DT: 17.02.2024NOS | $114.1K | 3 |
| MICROLUSS (CIPROFLOXACIN TABLETS USP 500MG) (10X10sX48802) - TAX INVOICE NO: 701208498 DT: 29.02.2024NOS | $106.7K | 3 |
| MICROFLOX 500 (CIPROFLOXACIN 500MG USP T | $100.0K | 2 |
| MICROLUSS CIPROFLOXACIN TABLETS USP 500MG 10X10sX59544 - TAX DOCUMENT NO: 712202715 DT: 16.11.2023 | $100.0K | 2 |
| MICROFLOX 500 (CIPROFLOXACIN TABLETS USP | $83.6K | 2 |
| MICROFLOX 500 ( (Ciprofloxacin Tablets U | $82.4K | 3 |
| MICROLUSS (CIPROFLOXACIN TABLETS USP 500MG) (10X10SX30187) - TAX INVOICE NO: 701208391 DT: 02.02.2024NOS | $66.5K | 3 |
| MICROLUSS (CIPROFLOXACIN TABLETS USP 500MG) (10X10SX24858) - TAX INVOICE NO: 701208391 DT: 02.02.2024NOS | $54.7K | 3 |
| MICROFLOX 500 ( (CIPROFLOXACIN TABLETS 500MG) ) ( 1X10S ) ( QTY- 98100.000 ) | $54.2K | 2 |
Micro Labs Limited exports 70 distinct Ciprofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MICROLUSS (CIPROFLOXACIN TABLETS USP 500 with 5 shipments worth $250.0K.
How Does Micro Labs Limited Compare to Nearest Ciprofloxacin Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | FDC LIMITED | $4.8M | 99 | 6 | $48.1K |
| 7 | MEDOPHARM | $4.5M | 91 | 19 | $50.0K |
| 15 | MICRO LABS LIMITED ★ | $4.2M | 101 | 11 | $41.8K |
| 8 | V S INTERNATIONAL PRIVATE LIMITED | $3.8M | 75 | 4 | $50.0K |
| 14 | BRAWN LABORATORIES LIMITED | $3.4M | 67 | 12 | $50.0K |
Micro Labs Limited ranks #15 among 1001 Indian Ciprofloxacin exporters. Average shipment value of $41.8K compared to the market average of $74.5K. The closest competitors by value are FDC LIMITED and MEDOPHARM.
Which Indian Ports Ship Ciprofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,828 | 12.9% |
| SAHAR AIR | 1,481 | 10.5% |
| NHAVA SHEVA SEA (INNSA1) | 1,254 | 8.9% |
| DELHI AIR CARGO ACC (INDEL4) | 969 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 766 | 5.4% |
| DELHI AIR | 722 | 5.1% |
| JNPT | 595 | 4.2% |
| Bombay Air | 375 | 2.7% |
Geopolitical & Trade Policy Impact on Micro Labs Limited's Ciprofloxacin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Ciprofloxacin, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ciprofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ciprofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 102 individual customs records matching Micro Labs Limited exporting Ciprofloxacin, covering 70 formulations to 13 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,081+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ciprofloxacin Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Ciprofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Ciprofloxacin Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ciprofloxacin. For current shipment-level data, contact TransData Nexus.